Heparin dose for accurate anticoagulation in cardiac surgery.
Donald B. Doty, Hurley W. Knott, J. L. Hoyt, J. A. Koepke
Abstract
Donald B. Doty, Hurley W. Knott, J. L. Hoyt, J. A. Koepke
Abstract
A simplified technique relating individual heparin dose to desired anticoagulant effect was used in 152 patients during cardiac surgery. Activated clotting time (act) was measured by semi-automated technique (Hemochron) before and after heparin, 200 U/kg I.V. Two point linear dose-response curve allowed calculation of any additional heparin required for uniform ACT of 480 seconds. Mean heparin requirement was 330 U/kg) (range 200--600 U/kg) mean requirements for adults (mean = 310 U/kg) were significantly less (p less than 0.001) than for children (mean = 430 U/kg). Individual dose-response curves suggested 20 patients (13%) could have been below adequate anticoagulant levels (ACT less than 300 seconds) using our previous formula for heparin dosage (9000 U/m2). At completion of cardiopulmonary bypass, measurement of ACT provided circulating heparin level from the dose-response curve. Protamine dose (1.3 mg/100 U. heparin) was individualized to precisely reverse anticoagulant effect to control ACT in 127 of 152 patients (84%) with a single dose. Elimination of patient and product variability by simplified semi-automated dose-response technique for heparin therapy provides uniform anticoagulant effect and its accurate neutralization. This technique is recommended for precise anticoagulant therapy during open heart surgery.
OpenAlex reports 33 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A simplified technique relating individual heparin dose to desired anticoagulant effect was used in 152 patients during cardiac surgery. Activated clotting time (act) was measured by semi-automated technique (Hemochron) before and after heparin, 200 U/kg I.V. Two point linear dose-response curve allowed calculation of any additional heparin required for uniform ACT of 480 seconds. Mean heparin requirement was 330 U/kg) (range 200--600 U/kg) mean requirements for adults (mean = 310 U/kg) were significantly less (p less than 0.001) than for children (mean = 430 U/kg). Individual dose-response curves suggested 20 patients (13%) could have been below adequate anticoagulant levels (ACT less than 300 seconds) using our previous formula for heparin dosage (9000 U/m2). At completion of cardiopulmonary bypass, measurement of ACT provided circulating heparin level from the dose-response curve. Protamine dose (1.3 mg/100 U. heparin) was individualized to precisely reverse anticoagulant effect to control ACT in 127 of 152 patients (84%) with a single dose. Elimination of patient and product variability by simplified semi-automated dose-response technique for heparin therapy provides uniform anticoagulant effect and its accurate neutralization. This technique is recommended for precise anticoagulant therapy during open heart surgery.
Key concepts: Heparin, Activated clotting time, Medicine, Protamine, Anticoagulant, Cardiopulmonary bypass, Anesthesia, Cardiac surgery